TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18812446

Group type: EXPERIMENTAL
Intervention: EBUS-TBNA plus conventional diagnostic procedures (CDPs)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Conventional diagnostic procedures (CDPs)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: EBUS probe within lesions
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: EBUS probe adjacent to lesions
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: TBNA
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: TBB
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: BW
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: EBUS-TBNA plus CDPs
Number of subjects: 202
Study: 16452699

Group type: EXPERIMENTAL
Intervention: Cognitive adaptation training
Number of subjects: 64

Group type: COMPARATOR
Intervention: Generic environmental supports
Number of subjects: 64
Study: 15086616

Group type: EXPERIMENTAL
Intervention: Biostite (test)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bio-Oss (control)
Number of subjects: 24
Study: 11699314

Group type: EXPERIMENTAL
Intervention: 0.25% timolol in Gelrite (n = 23)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Combination of 0.5% timolol plus 2% dorzolamide (n = 22)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 2% dorzolamide (n = 24)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Brimonidine (n = 26)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Gentamicin (control, n = 24)
Number of subjects: 119
Study: 9129790

Group type: COMPARATOR
Intervention: Standard low-birth weight milk formula
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-birth weight milk formula supplemented with nucleotides
Number of subjects: 27
Study: 7711421

Group type: EXPERIMENTAL
Intervention: Liposomal tretinoin (0.01%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Commercial gel preparation (0.025% or 0.05%)
Number of subjects: 20
Study: 31564388

Group type: EXPERIMENTAL
Intervention: Proteinuria group (n=446)
Number of subjects: 2536

Group type: COMPARATOR
Intervention: Non-proteinuria group (n=2048)
Number of subjects: 2536
Study: 31533578

Group type: EXPERIMENTAL
Intervention: Injectable contraceptive (IC)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Intrauterine device, sterilisation, or oral contraceptives
Number of subjects: 471

Group type: COMPARATOR
Intervention: Contraceptive services
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Overall contraceptive method mix
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Contraceptive discontinuation
Number of subjects: 471
Study: 28511656

Group type: EXPERIMENTAL
Intervention: Semiskeletonized ITA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional pedicled ITA
Number of subjects: 60
Study: 26297368

Group type: EXPERIMENTAL
Intervention: Minimalist shoes
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control shoes
Number of subjects: 76
Study: 23664773

Group type: EXPERIMENTAL
Intervention: IV ketamine 0.25 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: IV ketamine 0.5 mg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline (Control Group)
Number of subjects: 120
Study: 21241489

Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated) (DAA) at doses of 6, 12, 18, or 24 μg/kg/hour
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: COMPARATOR
Intervention: Enoxaparin (1 mg/kg body weight twice daily)
Number of subjects: 47
Study: 18457329

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Exercise Training (PRET)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standardized Therapeutic Exercise Protocol (TP)
Number of subjects: 52
Study: 16524979

Group type: EXPERIMENTAL
Intervention: Aprepitant regimen (aprepitant, ondansetron and dexamethasone on day 1; aprepitant and dexamethasone on days 2‐3; dexamethasone on day 4)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aprepitant regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control regimen (ondansetron + dexamethasone on days 1‐4)
Number of subjects: 0
Study: 12691509

Group type: EXPERIMENTAL
Intervention: Dianeal PD‐4 containing 0.1 g/L HA
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Dianeal PD‐4 containing 0.5 g/L HA
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control treatment (Dianeal PD‐4, 1.36% glucose)
Number of subjects: 13
Study: 11125779

Group type: EXPERIMENTAL
Intervention: Fast Track intervention (multisite, multicomponent preventive intervention including universal-level classroom program, social-skill training, academic tutoring, parent training, and home visiting)
Number of subjects: 0
Study: 8656727

Group type: EXPERIMENTAL
Intervention: Outpatient geriatric evaluation and management (GEM)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual outpatient primary care (UPC)
Number of subjects: 160
Study: 1557981

Group type: EXPERIMENTAL
Intervention: Heparin surface modified (HSM) intraocular lenses (IOLs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Regular polymethyl methacrylate (PMMA) intraocular lenses (IOLs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Regular PMMA IOLs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Heparin surface modified (HSM) IOLs and Regular PMMA IOLs
Number of subjects: 40
Study: 2866558

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desmethylimipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethasone suppression tests (DSTs)
Number of subjects: 0
Study: 31070229

Group type: EXPERIMENTAL
Intervention: Mesenchymal stromal cell (MSC) infusion, 2 million/kg intravenous infusions, administered twice in three patients.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Mesenchymal stromal cell (MSC) infusion
Number of subjects: 6
Study: 28926306

Group type: EXPERIMENTAL
Intervention: weekly group art therapy (1.5 hours, 10 weeks)
Number of subjects: 57

Group type: COMPARATOR
Intervention: waiting list group
Number of subjects: 57
Study: 27770809

Group type: EXPERIMENTAL
Intervention: Low-dose amitriptyline (25 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Active placebo (benztropine mesylate, 1 mg)
Number of subjects: 150
Study: 23682618

Group type: EXPERIMENTAL
Intervention: Intensive cognitive behavioral therapy (8-day duration)
Number of subjects: 56
Study: 22693121

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) using hexaminolevulinate (HAL) 40 mM with 3-hour application
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) for patients with CIN2
Number of subjects: 67
Study: 19907355

Group type: EXPERIMENTAL
Intervention: Inhaled epinephrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nasal decongestant
Number of subjects: 0
Study: 18091473

Group type: EXPERIMENTAL
Intervention: Mechanical traction during the first 2 weeks of a 6-week extension-oriented intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: No mechanical traction during the first 2 weeks of a 6-week extension-oriented intervention
Number of subjects: 64
Study: 16298288

Group type: EXPERIMENTAL
Intervention: Immune of Life for Teens module (experimental I group with intensive training)
Number of subjects: 1580

Group type: EXPERIMENTAL
Intervention: Immune of Life for Teens module (experimental II group with nonintensive training)
Number of subjects: 1580

Group type: COMPARATOR
Intervention: Control group (no application of the module)
Number of subjects: 1580
Study: 12085364

Group type: EXPERIMENTAL
Intervention: Lamivudine
Number of subjects: 805

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 805

Group type: COMPARATOR
Intervention: Interferon
Number of subjects: 805

Group type: COMPARATOR
Intervention: Lamivudine plus interferon
Number of subjects: 805
Study: 9468078

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 7665059

Group type: EXPERIMENTAL
Intervention: Tubal anastomosis
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: IVF
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (elective tubal ligation)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Giessen-test
Number of subjects: 33
Study: 2505716

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 57441

Group type: EXPERIMENTAL
Intervention: Transfer factor
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (physiological saline)
Number of subjects: 30
Study: 31043657

Group type: EXPERIMENTAL
Intervention: Burdock tea (1.5 g three times a day)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 161
Study: 27842468

Group type: EXPERIMENTAL
Intervention: FBO depression services
Number of subjects: 947
Study: 25146233

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Terbutaline
Number of subjects: 66
Study: 24229362

Group type: EXPERIMENTAL
Intervention: Multimodal intervention program including educational, physical, and social interventions.
Number of subjects: 240
Study: 21389149

Group type: EXPERIMENTAL
Intervention: Coadministration of RotaTeq and MenCC
Number of subjects: 247
Study: 19273702

Group type: EXPERIMENTAL
Intervention: Normal saline flushing via a positive-pressure cap
Number of subjects: 203

Group type: COMPARATOR
Intervention: Standard flushing with heparin solution
Number of subjects: 203
Study: 17290043

Group type: EXPERIMENTAL
Intervention: Infliximab 3 mg/kg
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Infliximab (both doses)
Number of subjects: 234
Study: 12768143

Group type: EXPERIMENTAL
Intervention: Transperitoneal surgical exposure
Number of subjects: 146

Group type: COMPARATOR
Intervention: Retroperitoneal surgical exposure
Number of subjects: 146
Study: 10859289

Group type: EXPERIMENTAL
Intervention: L-5-methyltetrahydrofolate (MTHF) at 17 mg/d
Number of subjects: 50
Study: 9106095

Group type: EXPERIMENTAL
Intervention: ARF treated liquefied porridge
Number of subjects: 28

Group type: COMPARATOR
Intervention: Porridge diluted with water
Number of subjects: 28
Study: 8244149

Group type: EXPERIMENTAL
Intervention: Chemotherapy with 5-epidoxorubicin emulsified in lipiodol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Symptomatic treatment
Number of subjects: 50
Study: 3510774

Group type: EXPERIMENTAL
Intervention: Milrinone (75 micrograms/kg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Dobutamine (14 micrograms/kg/min)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Milrinone (25 micrograms/kg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Dobutamine (5 micrograms/kg/min)
Number of subjects: 15
Study: 31676522

Group type: EXPERIMENTAL
Intervention: Sensation Awareness Focused Training (SÄ€F‐T), 1 session daily for 3 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 10
Study: 28251224

Group type: EXPERIMENTAL
Intervention: Diclofenac potassium (50 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paracetamol (1 gram)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ibuprofen (400 mg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Preoperative analgesics (general)
Number of subjects: 120
Study: 26931619

Group type: EXPERIMENTAL
Intervention: Oral steroids for 1 week
Number of subjects: 380

Group type: COMPARATOR
Intervention: Matched placebo for 1 week
Number of subjects: 380
Study: 25109754

Group type: EXPERIMENTAL
Intervention: Radial artery grafts in diabetic patients
Number of subjects: 529

Group type: EXPERIMENTAL
Intervention: Saphenous vein grafts in diabetic patients
Number of subjects: 529

Group type: EXPERIMENTAL
Intervention: Radial artery grafts in nondiabetic patients
Number of subjects: 529

Group type: EXPERIMENTAL
Intervention: Major adverse cardiac events in diabetic patients
Number of subjects: 529

Group type: COMPARATOR
Intervention: Major adverse cardiac events in nondiabetic patients
Number of subjects: 529
Study: 23091142

Group type: EXPERIMENTAL
Intervention: Bacillus subtilis ANSB060 (E60)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (C20, C40, C60)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (C40 and C60)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bacillus subtilis ANSB060
Number of subjects: 0
Study: 19667110

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 1507

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 1507
Study: 17697277

Group type: EXPERIMENTAL
Intervention: Levo-alpha-acetylmethadol (LAAM)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Methadone maintenance (MM)
Number of subjects: 315
Study: 14678340

Group type: EXPERIMENTAL
Intervention: Duloxetine 40 mg oral dose
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Duloxetine 20 mg day(-1), 30 mg day(-1), or 40 mg day(-1)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Duloxetine 20 mg day(-1), 40 mg day(-1), or 80 mg day(-1)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Duloxetine (various doses)
Number of subjects: 234
Study: 11822006

Group type: EXPERIMENTAL
Intervention: Omeprazole as an adjunct to endoscopic intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical prediction guide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doppler ultrasound examination of the ulcer base
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mechanical methods of hemostasis
Number of subjects: 0
Study: 10444645

Group type: EXPERIMENTAL
Intervention: Bicycle exercise (50% peak O(2) uptake)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Seated rest (Control session)
Number of subjects: 11
Study: 8577182

Group type: EXPERIMENTAL
Intervention: D‐methamphetamine (30 mg/70 kg) administered at 0930 h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: D‐methamphetamine (30 mg/70 kg) administered at 2130 h
Number of subjects: 10

Group type: COMPARATOR
Intervention: D‐methamphetamine (30 mg/70 kg)
Number of subjects: 10
Study: 2197892

Group type: EXPERIMENTAL
Intervention: Prostenone
Number of subjects: 66

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 66
Study: 39574

Group type: EXPERIMENTAL
Intervention: 0.50 mg MJ-9184-1
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.25 mg MJ-9184-1
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31436925

Group type: EXPERIMENTAL
Intervention: Fluoride varnish applied four times a year, every three months for two years
Number of subjects: 504

Group type: COMPARATOR
Intervention: Control group (no fluoride varnish)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Fluoride varnish
Number of subjects: 504
Study: 27863058

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (diet and physical activity)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90
Study: 25293728

Group type: EXPERIMENTAL
Intervention: Noncoplanar VMAT (NC-VMAT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Coplanar VMAT (co-VMAT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Noncoplanar IMRT (NC-IMRT)
Number of subjects: 10
Study: 23433279

Group type: EXPERIMENTAL
Intervention: CIT + EP
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CIT
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 24
Study: 20598897

Group type: EXPERIMENTAL
Intervention: Arthrocentesis and full coverage stabilizing splint
Number of subjects: 20

Group type: COMPARATOR
Intervention: Arthrocentesis only
Number of subjects: 20
Study: 19956161

Group type: EXPERIMENTAL
Intervention: Scripted 10-min interaction with a radiographer plus a booklet
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Booklet alone
Number of subjects: 867

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 867
Study: 16754583

Group type: EXPERIMENTAL
Intervention: Health Screening
Number of subjects: 3464

Group type: EXPERIMENTAL
Intervention: Health Screening and Discussion
Number of subjects: 3464

Group type: COMPARATOR
Intervention: Invited group
Number of subjects: 3464

Group type: COMPARATOR
Intervention: Internal control group
Number of subjects: 3464
Study: 15032285

Group type: EXPERIMENTAL
Intervention: Intravenous tramadol (IVA) - 20 mg bolus intravenously, PCA programmed to deliver 20 mg bolus with 10 mg/hour infusion rate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Epidural tramadol (EA) - administered epidurally 5 minutes before induction, PCA programmed to deliver 20 mg bolus with 10 mg/hour infusion rate
Number of subjects: 40
Study: 11696805

Group type: EXPERIMENTAL
Intervention: 20 microg desmopressin intranasally
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% saline solution (placebo)
Number of subjects: 40
Study: 9137792

Group type: EXPERIMENTAL
Intervention: TBI + melphalan 140 mg/m2
Number of subjects: 100

Group type: COMPARATOR
Intervention: melphalan 200 mg/m2
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High-dose treatment (both groups)
Number of subjects: 100
Study: 7970538

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (IAL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (Healon)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hydroxypropyl methylcellulose (Oculose)
Number of subjects: 60
Study: 6383734

Group type: EXPERIMENTAL
Intervention: SCH 370 cream (1% clotrimazole/0.05% betamethasone dipropionate)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Betamethasone dipropionate
Number of subjects: 331

Group type: COMPARATOR
Intervention: Clotrimazole
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: SCH 370 cream
Number of subjects: 331
Study: 30580246

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study: 30480393

Group type: EXPERIMENTAL
Intervention: Focal vibratory stimulation at 80 Hz
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Focal vibratory stimulation at 300 Hz
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 27
Study: 26568562

Group type: EXPERIMENTAL
Intervention: Quartile of patients with greater brain volume loss (BVL) at 24 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quartile of patients with least amount of brain volume loss (BVL) at 24 months
Number of subjects: 0
Study: 25095313

Group type: EXPERIMENTAL
Intervention: Nano hydroxyapatite (Nano‐HA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Calcium hydroxide (Dycal)
Number of subjects: 30
Study: 23534323

Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum treatment (3 times/day for 3 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluoride varnish
Number of subjects: 60
Study: 21129077

Group type: EXPERIMENTAL
Intervention: Lifestyle program provided by nurse practitioners (NPs)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Enhanced standard care
Number of subjects: 58
Study: 18246895

Group type: EXPERIMENTAL
Intervention: Cryotherapy (ice bag secured to the lateral ankle joint for 20 minutes)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 27
Study: 16679671

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 15679251

Group type: EXPERIMENTAL
Intervention: Curative surgical resection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: More radical resection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant treatment strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant or adjuvant treatments
Number of subjects: 0
Study: 11005744

Group type: EXPERIMENTAL
Intervention: Strategy training for apraxia
Number of subjects: 33
Study: 8874339

Group type: EXPERIMENTAL
Intervention: Vinorelbine (30 mg/m2/week)
Number of subjects: 216

Group type: COMPARATOR
Intervention: 5-FU/LV (425 mg/m2 and 20 mg/m2 for 5 consecutive days every 4 weeks)
Number of subjects: 216
Study: 1900012

Group type: EXPERIMENTAL
Intervention: rt-PA
Number of subjects: 352

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 352
Study: 6383740

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 8 mg four times daily (qid)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 64 mg every other day (qod)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 31129354

Group type: EXPERIMENTAL
Intervention: HLA-matched unrelated donor (MUD) hematopoietic stem cell transplantation (HSCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immunosuppressive therapy (IST) with eltrombopag
Number of subjects: 0
Study: 27477840

Group type: EXPERIMENTAL
Intervention: Lanolin (n = 93)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Usual postpartum care (n = 93)
Number of subjects: 186
Study: 25880227

Group type: EXPERIMENTAL
Intervention: GAME intervention (goal-oriented activity-based, environmental enrichment therapy programme)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 13
Study: 23708871

Group type: EXPERIMENTAL
Intervention: Vitamin E (800 IU/day for 1 week before to 4 weeks after I therapy)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 36
Study: 21136299

Group type: EXPERIMENTAL
Intervention: Atomoxetine (1.2 mg/kg body weight)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 180

Group type: COMPARATOR
Intervention: Atomoxetine and Placebo
Number of subjects: 180
Study: 19026481

Group type: EXPERIMENTAL
Intervention: Fuji II (encapsulated resin-modified glass ionomer)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Permite (amalgam)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Filtek-Z-250/Single Bond (composite resin)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Keta Molar (conventional glass ionomer)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (composite resin)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vitremer (resin-modified glass ionomer)
Number of subjects: 20
Study: 16443706

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 mug twice daily
Number of subjects: 634

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 634
Study: 15539019

Group type: EXPERIMENTAL
Intervention: Escin (300 mg, b.i.d.)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Loratadine (10 mg, q.d.)
Number of subjects: 51